Piera Federico

7PUBLICATIONS
27CO-AUTHORS
Haematological tumoursMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.

Rodolfo Sacco, Edoardo G Giannini, Raffaella Tortora

|Jan 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.

Rodolfo Sacco, Daryl Ramai, Raffaella Tortora

|Dec 23, 2022
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact.

Piera Federico, Emilio Francesco Giunta, Andrea Tufo

|Aug 27, 2021
Epigenetic Regulation in Melanoma: Facts and Hopes.

Emilio Francesco Giunta, Gianluca Arrichiello, Marcello Curvietto

|Apr 30, 2021
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.

Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo

|Apr 03, 2021
How to Treat Hepatocellular Carcinoma in Elderly Patients.

Piera Federico, Emilio Francesco Giunta, Annalisa Pappalardo

Pageof 2

Frequent Collaborators

6 joint publications

Bruno Daniele

5 joint publications

Angelica Petrillo

4 joint publications

Emilio Francesco Giunta

2 joint publications

Andrea Tufo